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ABSTRACT 
Objective: This study aims to investigate the sub-acute oral toxicity of a methanolic leaf extract of Clinacanthus nutans (MECN) in male and female mice.  
Methods: The study used three groups of male and female mice, the crude MECN was dissolved in distilled water and administered orally in single 
doses of 1000 and 2000 mg/kg body weight for 28 d by gavage, at a dosing volume of 10 ml/kg body weight, while the control group received only 
the distilled water. Mice were weighed weekly for the duration of the study period. After the treatment period, the blood samples were collected 
and examined for hematology changes, total red blood cell (RBC) and total white blood cell (WBC), packed cell volume (PCV) and plasma protein 
concentration. The serum was analyzed for liver and kidney function test. The degree of injury of the liver and kidney tissue was histopathologically 
assessed and scored under the light microscopy. one-way analysis of variance (ANOVA) with Turkey’s test was used to analyze the difference 
(p<0.05) of means across treatment groups.  
Results: There were no significant (p>0.05) changes in the body weight, hematological, biochemical and histology signs of toxicity for both male 
and female mice, except for the sodium level which was decreased in the mice treated with 2000 mg/kg of MECN (137±5.06) as compared to the 
1000 (151±1.91) mg/kg as well as the control males (152±3.74) [F=4.87, p=0.03]. 
Conclusion: This study showed that MECN at dosages up to 2000 mg/kg is safe to be used in mice regardless of their sex. Overall, this study 
suggests the potential utility of MECN in the development of herbal drug formulations in vivo.  
Keywords: Clinacanthus nutans, Toxicity, Body weight, Blood liver function, Blood kidney function 




Clinacanthus nutans (Lindau) is a species of plant that belongs to the 
Acanthaceae family. This plant has been used as a folk medicine in 
different parts of Asia and more particularly in Malaysia, Thailand 
and Indonesia [1]. Recent research has suggested that Clinacanthus 
nutans be used in traditional and therapeutic practices however this 
proposition remains clinically and scientifically not supported yet 
[2]. The traditional herbs and herbal products are considered 
nontoxic and have been used by the general public and traditional 
medicinal doctors to treat various ailments. To the best of our 
knowledge, there are some studies which showed that Clinacanthus 
nutans contains a wide range of bioactive compounds including 
phenolic, flavonoid, �-sitosterol, stigmasterllupeol, belutin and 
chlorophyll derivatives. The C-glycosidic flavones such as shaftoside, 
isoorientin, orientin, isovitexin and vitexin have been found to be 
major flavonoids in the leaves of this plant [1, 3, 4]. Polyphenols 
have anti-oxidative, anti-inflammatory and neuroprotective effects 
signifying the natural defense properties of plant-based foods. 
Polyphenols have also been shown to exhibit anti-atherosclerotic 
activities and improve the endothelial function of blood vessels [5]. 
The World Health Organization reported that tree quarters of the 
world's population depends on plant-established medicines, 
especially in the developing countries where the poverty and lack of 
modern medicine have made the role of medicinal herbs relatively 
common [6]. Despite the crucial role that traditional herbs play in 
ensuring the well-being of thousands of people, empirical evidence 
that supports its use remains largely lacking [6]. Fundamentally, the 
basic idea is to utilize medicinal plants for the development of 
standardized phytomedicines (phytotherapics or herbal medication) 
with demonstrated efficacy, safety and high quality [7]. Instead of 
spending several millions of dollars and several years of research on 
developing a new synthesized drug, even from the prototype of a 
natural source the development of standardized phytomedicines 
would arguably require lesser funds and be more affordable and 
achievable in developing and underdeveloped countries [6]. 
Evaluations suggest that over 90% of the market withdrawals were 
due to reports of drug toxicity, specifically hepatotoxicity and 
cardiovascular toxicity [8]. What’s more, thousands of people die 
every year from the supposedly safe over the counter drugs but the 
number of deaths caused by traditional herbs is so rare according to 
the National Poison Control Centers in USA [9]. It is a common 
fallacy that herbal medications are free from any adverse effects. 
Plants have many constituents and some are extremely lethal [7]. 
Toxicity is the degree to which a substance or a chemical (toxin or 
poison) is able to harm a human or an animal. Any adverse effect 
that leads to functional impairment and the development of 
biochemical lesions may harm the organism [10]. Research on 
toxicity ordinarily uses animals to determine the effect of a 
particular action on the biological system of animals and thus to 
extrapolate results and doses on humans. The toxicity data is thus is 
essential to identifying the optimal therapeutic dose to which the 
extract can be given and the degree of lethality can be determined 
[11]. However, they are useful to provide information on how to 
determine the dosage in animal research. The organization for 
economic cooperation and development (OECD) has provided 
guidelines for assessing the preclinical acute and sub-acute toxicity 
[12]. The acute exposure refers to the time period in which animals 
are exposed to chemicals for less than 24 h. Established on the 
information received from this exposure, one may estimate the 
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lethal dose (LD50) or find out the extent to which the dosage can be 
safe. The data could also provide an insight into which one can 
assess the pharmacological effects for different traditional medicines 
of natural source [13]. Sub-acute exposure refers to a procedure 
through which animals are repeatedly exposed to a chemical over a 
period of 1 mo and sometimes less. The exposure period for sub-
chronic and chronic toxicity is usually 1 to 3 mo and 3 mo, 
respectively [13]. So, evaluating toxicity of Clinacanthus nutans in 
mice is crucial to determine the level of safety of a certain dosage of 
Clinacanthus nutans as plant-based medicines and to assess its 
pharmacological applications. This study aims to investigate the sub-
acute oral toxicity of a MECN in male and female ICR mice by 
evaluation of the hematological and biochemical parameters and 
histopathological examination. 
MATERIALS AND METHODS 
Plant materials 
Fresh leaves of Clinacanthus nutans (Burm. f.) Lindau was acquired 
from a botanical garden in Ladang 10, Serdang, Selangor Darul 
Ehsan, Malaysia. The botanical identify of Clinacanthus nutans was 
characterized by the Phytomedicine Herbarium, Institute of 
Bioscience, 43400 Serdang, Selangor Darul Ehsan, Malaysia(Voucher 
no. SK2942/15)  
Preparation of MECN 
The extracts were prepared according to the method of Lau et al. 
[14] with some modifications [14]. The Clinacanthus nutans leaves 
were cleaned under running tap water, and then air dried for one 
week under direct sunlight. These leaves were oven-dried for 24 h at 
40 °C in an oven, grounded to a fine powder by electric grinder (RT-
08, Rong Tsong Precision Technology Co. Taiwan) and stored in an 
air-tight container. The powdered leaves were extracted using 80% 
methanol by adding 20% of distilled water at a ratio of 1:20 (w/v), 1 
g of the sample to 20 ml of methanol. The powdered Clinacanthus 
nutans leaves were left macerated in methanol and shaken for 72 h 
using a rotary shaker (Liquid Brushless DC motor clock Rotary, 
Germany). Next, the methanol solution was separated from the 
powdered leaves by using a cloth filter, cotton wool and Whatman 
no. 1 filter paper (Whatman No.1, Fitchburg, WI, USA). The methanol 
extract was then concentrated under compact pressure with a 
rotating evaporator (R-215, Buchi, Flawil, Switzerland) at 40 °C. The 
concentrated methanol extract was stored at-80 °C and lyophilized 
with a freeze drier (Labconco Free zone 6 Plus Freeze Dryer) to dry 
powdered form and then kept at-20 °C. The yield obtained from the 
MECN was 15.92% (w/w). 
Animal model 
Male and female ICR mice aged eight weeks, weighing 24±2 g were 
purchased from Sapphire Enterprise, Malaysia. They were housed 
under standard environmental conditions of temperature at 22±1 
°C, humidity in the range of 40-70% and exposure to 12 h of 
light/dark cycle, acclimatized in the laboratory for seven days before 
commencing the experiment. Commercial food pellets (Gold Coin 
Sdn. Bhd., Port Klang, Malaysia) and water were supplied ad libitum 
from the beginning of the experiment. All procedures conducted in 
this work had been reviewed and approved by the UPM Institutional 
Animal Care and Use Committee, approval no: R083/2016. 
Study design of sub-acute oral toxicity 
Fifty mice are comprising 25 males and 25 females, were randomly 
assigned to three male groups (n=7 to 9 per group) and three female 
groups (n=7 to 9 per group). The 28 d oral dose toxicity was carried 
out following the OECD test guide 407 [15]. The crude MECN was 
administered orally in single doses of 1000 and 2000 mg/kg body 
weight for 28 d by gavage. There was the daily observance of the 
mice for any mortality and signs of toxicity. They were weighed 
weekly for the duration of the study period. All mice could freely 
access water and commercial chow ad libitum. The 12 h prior to 
sacrifice the animals were deprived of food but had free access to 
water. The mice were anesthetized with ketamine 80 mg/kg and 
xylazine 10 mg/kg given the intraperitoneally and then sacrificed 
through terminal exsanguination after 28 d of MECN treatment.  
Blood sampling 
Blood samples were collected through cardiac puncture by using 1 
ml syringe with 26-gauge needle and transferred into plain tubes. 
Blood with EDTA-containing tube (Sigma Chemical, St. Louis, MO) 
was mixed well to prevent clotting stored on ice. Serum samples 
were isolated by blood centrifugations at 3000 rpm (Universal 320R, 
Hettich, Germany) for 15 min and kept at-80 °C until further analysis 
of biochemical parameters.  
Relative organ weights 
Liver, kidney, spleen, and heart were removed from the euthanized 
animals, rinsed in 0.9% saline, carefully dissected and weighed on an 
analytical scale. The relative organ weight (RW) for each organ was 




 × 100% 
RW: Relative organ weight, AW: absolute organ weight (g), BW: body 
weight of mice on the day of sacrifice [16]. The selected organs (liver 
and kidney) were then secured in 10% formalin for 
histopathological examination.  
Hematological analysis  
RBC and WBC counting 
Hemocytometer set was used to determine the total RBC, and total 
WBC counts. Blood samples were diluted with formal citrate consists 
of 3g tri-sodium citrate dihydrate (Merck, Germany) 1 ml of 37% 
formaldehyde solution (Merck, Germany) dissolved in 100 ml of 
distilled water prior to RBC counting, while Turks solutions (Merck, 
Darmstadt, Germany) consisting of glacial acetic acid 2 ml, 1% 
gentian violet 1 ml, in 100 ml distilled H2O was used as the WBC 
diluent. Counting methods and their diluents were as described by 
Piersma et al. [17].  
Determination of hematocrit 
Determination of microhematocrit was carried out as described by 
Piersma et al. [17]. Briefly, micro-hematocrit capillary tubes 
(Fisher Scientific, Pittsburgh) were filled up to about a third of the 
capillary with blood from the EDTA tubes. The capillary tubes 
were then wiped clean with a tissue and sealed. The capillary 
tubes were placed in a microhematocrit centrifuge (Hettich 
Haematocrit, 210, Germany) and centrifuged at 10 000 rpm for 5 
min. This procedure was carried out to separate blood and plasma. 
The hematocrit value was then read using a microhematocrit 
reader (Hawksley Ltd, England). The PCV% was recorded from the 
reader and converted into a % (l/l).  
Plasma protein determination 
The centrifuged capillary tubes were also subjected to plasma 
protein concentration measurements. The top of the capillary tube 
was broken, and the plasma liquid was poured onto a prism 
refractometer (Atago T2-NE, Japan). The concentration of plasma 
protein was established by examining the refractometer and the 
concentration values were read according to the scale. 
Serum biochemical analysis 
Serum samples were analyzed in an automated chemistry analyzer 
(TRX 7010, Biorex Mannheim, Germany). The biochemical 
parameters were analyzed and the liver function test was used to 
establish the amount of total protein (g/I), albumin (g/l), globulin 
(g/l), albumin/globulin, G-Glutamyltransferase (U/l), total bilirubin 
(μmol/l), alkaline phosphate (U/l), aspartate aminotransferase 
(U/l), cholesterol (mmol/l) and triglyceride (μmol/l). In order to 
assess the effect on renal function tests were conducting using 
sodium (mmol/l), potassium (mmol/l), chloride (mmol/l), urea 
(mmol/l) and creatinine (mmol/l). 
Histopathological examination of the liver and kidney  
The liver and kidney organs were washed with normal cold saline 
and fixed in 10% buffered formalin for 48 h. Following fixation, 
organs were trimmed to 4 mm thickness and placed in plastic 
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cassettes, prior to processing overnight using a standard method in 
an Automatic Tissue Processor (Leica TP1020, Germany). The 
tissues were then embedded in paraffin with Leica EG 1160 (Leica 
Microsystems, Germany) [18] and then cut to 5 μm thickness using a 
rotary microtome (Leica RM2135, Germany). The tissue sections 
were placed in a water bath (Leica H1210, Germany) at 35 °C to 37 
°C and then mounted on glass slides using a slide warmer (Lab-line 
Instruments, model 26007, Melrose Park, USA) and stained with 
hematoxylin and eosin (HandE) stain, by using Tissue-TekPrisma-
EzsAutostainer (Sakura, Torrance, CA) [18]. The Olymphus-CX31 
light microscope (Olympus, Japan) was then used for the 
examination of the tissues. The degree of injury of the liver and 
kidney was assessed and scored under the light microscopy. 
Toxicity scoring  
Numerical scores were obtained by both staging and grading, which 
provided a semi-quantitative evaluation of the observed histological 
feature. Pathological changes were scored on the basis of the 
toxicity, namely inflammation and activated Kupffer cells, while 
hydropic degeneration affected cells showed vacuoles in cytoplasm 
and necrosis in the liver. Meanwhile, for the kidney tissue, lesions 
such inflammation, hydropic degeneration/cytoplasmic vacuolation 
and necrosis were studied and scored. Table 1 shows the scoring 
system used for histopathology evaluation of the liver and kidney 
tissues. The possible hepatoprotective and nephroprotective effects 
of Clinacanthus nutans were also evaluated in the group treated with 
1000 and 2000 mg/kg MECN for both sexes. 
  
Table 1: The scoring of toxicity effect in liver and kidney of mice [19]. 
Score Grade Description 
0 Normal No toxicity. 
1 Mild 1-30% 
2 Moderate 31-70% 
3 Severe ˃ 71% 
 
Statistical analysis 
Data on body weight, organ weight, hematology, serum biochemical 
parameters and histopathological examination were analyzed using 
the one-way analysis of variance (ANOVA) procedure of the SAS 
software package, version 9.1 (SAS Institute Inc., Cary, NC). This was 
followed by Tukey’s test for post hoc comparison of group means. 
Differences were accepted as statistically significant when p-
value<0.05. Data are presented as mean±standard error of the 
means (SEM). 
RESULTS 
Clinical observation and body weight  
In the sub-acute oral toxicity experiment with a MECN 1000 and 
2000 mg/kg, the results reported no significant changes in the 
average body weight of the mice, particularly in their behavior 
abnormalities, skin effect, hair loss, breathing, and postural 
abnormalities. There were neither toxicity signs nor mortality 
records among both control and treatment groups in the next 4 h, 24 
h and even throughout the 28 d of the experiment. The mice, 
whether males and females or treated with Clinacanthus nutans or 
vehicle ones, has remained normal throughout the trail. A weekly 
record of the average body weight of mice in subacute oral toxicity 
study of MECN, the body weight for the control group, 1000 and 
2000 mg/kg for male and female groups have steadily increased 
between week 1 and week 4. For the male mice, the body weight 
(mean±SEM) was 36.33±0.33 g for the control group, 35±0.31 g for 
male mice treated with 1000 mg/kg and 35.20±0.58 g for the mice 
treated with 2000 mg/kg. As shown in fig. 1, no significant variance 
(p>0.05) were observed between groups [F=1.91, p= 0.19]. 
  
 
Fig. 1: Effects of MECN on body weight of male mice across treatment groups, values are expressed as mean±SEM (n=7) 
 
 
Fig. 2: Effects of MECN on body weight of female mice across treatment groups, values are expressed as mean±SEM (n=7) 
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However, the body weight of the female mice was 29.83±0.94 g 
among the control animals 27.87±0.44 g for female mice treated 
with 1000 mg/kg and 27.33±0.47 g for the female mice treated with 
2000 mg/kg. As shown in fig. 2, no significant (p>0.05) variances 
were observed between groups [F=1.89, p=0.17]. There were no 
significant (p˃0.05) changes observed in the body weight of the mice 
treated with MECN across treatment groups and gender during the 
study period. 
Macroscopic examination and organ weights 
The weights of internal organs are used as the indicators of 
metabolic function. Relative weights of internal organs have been 
termed morph-physiological indices. The organs of the control and 
treatment mice were examined for appearance and size. There were 
no significant changes observed in the weight of the organs for both 
the control and MECN treated groups of both sexes. Similarly, the 
results did not show any significant changes in the weights of liver, 
kidney, spleen, and heart. There were no significant differences 
(p˃0.05) between both sexes in the control and treatment groups 
(table 2). 
Hematology and blood biochemistry  
Table 3 below shows the effect of subacute oral toxicity of MECN on 
the hematological parameters, specifically the RBC, WBC, PCV and 
plasma protein had no significant differences (p˃0.05) between the 
MECN treated groups of both sexes of 1000 and 2000 mg/kg as 
compared to the control groups during the study period. The 
biochemical parameters of the MECN treated and control groups are 
as shown in Tables 4 and 5. The parameters pertaining to liver and 
kidney functions remained constant in the MECN treated and control 
groups for both sexes. However, there was a significant decrease 
(p<0.05) in the level of sodium in the MECN treated mice 2000 
mg/kg as compared to the 1000 mg/kg as well as the control males 
[F=4.87, p=0.03]. 
  
Table 2: Effects of MECN on relative organ weight of male and female mice 
Relative organ weight Control 1000 mg/kg 2000 mg/kg  p-value  
Male      
Liver (%) 6.04±0.53a 5.38±0.49a 5.75±0.70a 0.76 
Kidney (%) 1.48±0.09a 1.12±0.13a 1.56±0.24a 0.22 
Spleen (%) 0.72±0.14a 0.65±0.07a 0.85±0.17a 0.56 
Heart (%) 0.55±0.02a 0.55±0.03a 0.61±0.05a 0.42 
Female     
Liver (%) 4.78±0.40a 4.83±0.28a 4.76±0.40a 0.99 
Kidney (%) 1.62±0.10a 1.51±0.04a 1.39±0.11a 0.26 
Spleen (%) 0.53±0.06a 0.54±0.03a 0.63±0.09a 0.59 
Heart (%) 0.51±0.04a 0.45±0.03a 0.44±0.02a 0.42 
Values are expressed as mean±SEM (n=7). Means within a row with the same superscript letters are not significantly different (p>0.05, ANOVA) 
between groups by Tukey’s test.  
 
Table 3: Effects of MECNon hematological parameters of male and female mice 
Blood parameters Control 1000 mg/kg 2000 mg/kg p-value  
Male      
Red blood cell (×10[12]/l) 9.08±0.21a 9.17±1.19a  9.24±1.26a 0.99 
White blood cell (×109/l) 5.83±0.60a 5.37±0.42a 5.50±0.28a 0.70 
Packed cell volume (L/l)  0.27±0.01a  0.25±0.05a  0.26±0.01a 0.48 
Plasma protein (g/l)  110±0.10a  116±0.4a  113±0.7a 0.85 
Female      
Red blood cell (×10[12]/l) 8.82±0.94a  9.11±0.19a  9.96±0.44a 0.17 
White blood cell (×109/l) 4.83±0.60a  4.0±0.76a  5.50±0.28a 0.26 
 Packed cell volume (L/l)  0.22±0.01a 0.27±0.04a  0.23±0.02a 0.32 
Plasma protein (g/l) 119±1.76a  117±2.88a  115±2.88a 0.41 
Values are expressed as mean±SEM (n=7). Means within a row with the same superscript letters are not significantly different (p<0.05, ANOVA) 
between groups by Tukey’s test.  
 
Table 4: Effects of MECN on biochemical parameters of male mice 
Male  Control 1000 mg/kg 2000 mg/kg   p-value  
Liver function tests  
Total protein (g/l) 82.73±3.03a  86.20±3.12a 84.86±3.12a 0.64 
Albumin (g/l) 47.50±5.93a 47.40±5.97a 48.40±6.59a 0.98 
Globulin (g/l) 32.20±1.72a 32.60±1.60a 31.00±1.60a 0.91 
G-Glutamyl transferase (U/l) 4.0±3.0a 4±2.0a 5.33±2.0a 0.86 
Total bilirubin (μmol/l) 9.60±0.30a 9.01±0.31a 11.80±1.27a 0.45 
Alkaline phosphate (U/l) 165±38.0a 112±14.0a  110±52a 0.54 
Cholesterol (mmol/l) 8.70±0.01a 5.85±0.08a 7.65±1.4a 0.13 
Triglyceride (mmol/l) 4.71±0.12a 2.68±0.85a 4.87±1.30a 0.30 
Kidney function tests  
Sodium (mmol/l) 152±3.74a 151±1.91a 137±5.06b 0.03 
Potassium (mmol/l) 26.93±1.29a 23±2.91a 24.73±2.54a 0.71 
Chloride (mmol/l) 103.33±2.66a 100±3.05a 96±2.58a 0.16 
Urea (mmol/l) 3.43±0.44a 3.35±0.46a 3.16±0.54a 0.92 
Creatinine (mmol/l) 43.85±1.43a 42.17±0.81a 40.00±0.40a 0.06 
Values are expressed as mean±SEM (n=7). Means within a row with different superscript letters are a significant difference (p<0.05, ANOVA) 
between groups by Tukey’s test.  
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Table 5: Effects of MECN on biochemical parameters of female mice 
Female Control 1000 mg/kg 2000 mg/kg  p-value 
Liver function tests   
Total protein (g/l)ns 77.30±6.90a  73.40±2.60a  69.80±5.60a 0.66 
Albumin (g/l)ns 53.90±6.00a 45.06±3.65a  41.50±3.52a 0.20 
Globulin (g/l)ns  29.73±3.72a 30.33±4.87a  30.73±2.11a 0.18 
G-Glutamyl transferase (U/l)ns 5.33±1.76a 2.0±0.04a 2.0±0.04a 0.09 
Total bilirubin (μmol/l)ns 13.47±2.29a 11.0±1.20a  7.73±1.87a 0.53 
Alkaline phosphate (U/l)ns 86±8.0a 84.67±12.0a 76±5.17a 0.97 
Cholesterol (mmol/l)ns 6.90±2.70a 6.45±1.05a 4.80±1.20a 0.71 
Triglyceride (μmol/l)ns 4.81±1.66a 4.20±0.33a  2.68±0.37a 0.41 
Kidney function tests  
 Sodium (mmol/l)ns 130.0±0.6a  132.0±1.8a  116.0±2.2a 0.78 
 Potassium (mmol/l)ns  23.8±6.1a 23.0±1.6a  21.20±4.60a 0.93 
Chloride (mmol/l)ns 96.0±7.57a 89.0±11a  87.0±5.0a 0.71 
Urea (mmol/l)ns 3.37±0.91a 3.25±1.24a 3.10±0.57a 0.98 
Creatinine (µmol/l)ns 41.83±1.52a 41.16±0.49a 41.05±0.88a 0.85 
Values are expressed as mean±SEM (n=7). Means within a row with different superscript letters are significant difference (p<0.05, ANOVA) between 
groups by Tukey’s test.  
 
Histopathology of liver and kidney 
The results obtained from liver and kidney tissues are summarized 
in table 6. No significant gross changes were detected in liver and 
kidneys tissues in all groups and across both sexes (fig. 3 to fig. 6). 
Inflammatory cell infiltration, necrosis, and hemorrhage were 
absent in the treated animals. There were also no changes observed 
in the central vein, portal vein, hepatocytes, sinusoids, and bile 
ducts. There were no changes in the structure of kidneys with 
respect to glomeruli, distal and proximal tubules. The scoring of liver 
and kidney tissues were made by a pathologist who was blinded to 
the treatment groups. 
Tissue changes were not detected in the control group. 
  
Table 6: Necropsy of MECN in male and female mice across treatment groups 
Organ/group Result Control (vehicle)a 1000 mg/kga 2000 mg/kga 
Male      
Liver  Normal 6/6 6/6 6/6 
 Toxicity present  0/6 0/6 0/6  
Kidney  Normal 6/6 6/6 6/6 
 Toxicity present 0/6 0/6 0/6 
Female      
Liver Normal 6/6 6/6 6/6 
 Toxicity present 0/6 0/6 0/6 
Kidney  Normal 6/6 6/6 6/6 
 Toxicity present 0/6 0/6 0/6 
aThe values stated are indicated for 6 mice per group, as observed animals or (number of animals having toxicity)/(total number of animals).  
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Fig. 3: Liver tissue in male mice across treatment groups. MA: male control group, MB: male mice treated with 1000 mg/kg MECN, MC: 
male mice treated with 2000 mg/kg MECN. No cellular structural changes were detected in both the treated and control groups. H: 
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Fig. 4: Liver tissue in female mice across treatment groups. FA: female control group, FB: female mice treated with 1000 mg/kg MECN, FC: 
femalemice treated with 2000 mg/kg MECN. No cellular structural changes were detected in both the treated and control groups. H: 





Fig. 5: Kidney tissue in male mice across treatment groups. MA: male control group, MB: male mice treated with 1000 mg/kg MECN, MC: 
male mice treated with 2000 mg/kg MECN. No cellular structural changes were detected in both the treated and control groups. G: 
glomeruli, BC: glomerular capsule, PT: proximal convoluted tubule, DT: distal convoluted tubules (HE staining, scale bar=10 µm, original 
magnification x200) 
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Fig. 6: Kidney tissue in female mice across treatment groups. FA: female control group, FB: female mice treated with 1000 mg/kg MECN, 
FC: female mice treated with 2000 mg/kg MECN. No cellular structural changes were detected in both the treated and control groups. G: 




The extracts of these plants and their isolated compounds are 
usually screened for toxicity before their usage [20]. The rapid 
growth of herbal supplements, health functional foods, and 
functional drinks has recently resulted in high demand in the herbal 
industry. The increasing demand for alternative medicine has 
encouraged many people to use herbal products like the traditional 
Chinese medicine Ayurveda and Jamu [19]. Due to their medicinal 
benefits and their minimal side effects, the phytochemical 
compounds of medicinal plants are being more widely used than 
synthetically-based drugs[21]. In response to these demands, the 
present study has examined the quality and degree of safety of the 
MECN. The results of the study are reported and discussed below. 
Oral gavage is the most convenient method for testing the toxicity in 
plant extracts [22]. Similarly, Rhiouani et al. [23] found that 
decreases in body weight at the onset of treatment are possible due 
to the normal physiological adaptation reactions to the plant 
extracts or compounds, which indicates a normal metabolism of 
important nutrients such as carbohydrate, protein and fat. The 
results of the present study showed that the repeated administration 
of the extract over a period of 28 d induced increases in the body 
weight of the animals. All the animals exhibited normal weight and 
behavior pattern with no significant changes between the groups. 
Furthermore, the physical appearance did not exhibit any changes, 
and thus there was a normal gain in the body weight. It is possible 
that this observation was due to environmental factors [24]. 
Therefore, the treatment of mice with MECN showed no adverse 
effects during their growth over the duration of the experiment. The 
results of the present study are in line with other previous findings 
[19,25]. Additionally, the macroscopic observation of the systemic 
organs showed no changes in the primary organs of the MECN-
treated and control groups. The oral administration of MECN did not 
cause any adverse effects on the organ weight. Thus, the effect was 
similar between the groups and the results were not statistically 
significant. These results are in line with other similar works [25]. 
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According to Auletta[26] changes in the body weight and organ 
weight of the animal are indications of the presence of toxicity [27]. 
If the body weight of the animal is reduced to 10% of its initial 
weight, then the administration of extract is considered toxic. The 
changes that occur in the relative organ weight of the animal can 
also be due to the pathological status of animals. It is an important 
parameter in the preliminary diagnosis of the organ exposure to 
injury [28]. The relative organ weight is essential for finding out if the 
organ had any damage during treatment. In drug metabolism context, 
the liver, kidney, spleen and heart are the main organs that are more 
susceptible to reactions in the presence of toxicants [29]. Using 
Swietenia macrophylla crude seeds extract suspended in olive oil, 
Balijepalli et al. [30] found no casualties among rats and the dose was 
safe up to 2000 mg/kg. Similarly, this study found no significant 
changes in the relative weight of organs, as well as in the body weight 
of all mice of both sexes, whether in the treatment or control groups. 
Collectively, these indicate that MECN is not toxic up to 2000 mg/kg.  
The hematopoietic system serves as an important target for the toxic 
chemicals. It is a sensitive index for the physiological and 
pathological status in humans and animals [31]. The RBCs and 
sometimes referred to as erythrocytes are a type of blood cell that 
transports oxygen to the body tissues and cells. It also transports the 
metabolic waste products to the kidneys and liver to filter and 
excrete. Low RBCs are usually associated with anemia [32]. Adedapo 
et al. [33] found that using crude aqueous extracts of Euphorbia over 
a period of 14 d of oral feeding led to low RBCs (anemia) in albino 
rats. This is in contrast to the finding reported by Okokon et al. [34]. 
They found that the use of ethanol extract of crude root of Croton 
zambesicus for 21d resulted in an increase of RBCs and WBCs in rats. 
This is contrary to the extract stimulating erythropoiesis and 
leukocytosis, which could be due to the alkaloids present in the 
extract. Alkaloids could cause similar effects by inhibiting 
phosphodiesterase that could result in the accumulation of cyclic 
adenosine monophosphate which in turn stimulates protein 
synthesis [34]. The sub-acute oral toxicity of MECN in the present 
study did not cause any significant differences in the hematological 
parameters RBC, WBC, plasma protein and PCV between the control 
and MECN treated groups for both sexes. This demonstrates that 
MECN was safe on the bone marrow function in mice. This result is 
in line with other findings in the literature[19, 25, 35]. This result 
also supports a considerable number of necropsy observations, 
where no injuries to any hematopoietic organs were reported, and 
no changes in the histopathology were found.  
Serum biochemical analysis provides an important tool to assess the 
effects of herbal extracts in tissue [19]. The common biomarkers for 
liver damage include alkaline phosphate, serum albumin and total 
protein [36]. It is known that the liver is the main region of 
xenobiotic metabolism. The results of the present study did not 
show any significant changes in the liver serum biomarkers between 
treatment groups and control groups. According to previous 
research, the increases in the serum levels of alkaline phosphate 
were attributed to the lipid peroxidation of hepatocyte members 
[37]. Their data also demonstrated that there were increases in the 
sepsis which activated to the nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-kB) in the liver and induction of 
hepatocellular injury [38]. Plants and herbs extracts were used to 
inhibit NF-kB activation in vitro [39]. The serum alkaline phosphate 
level in the mice was similar to the reports given in the present 
study. Final assessment of alkaline phosphate in serum after 28 d of 
treatment showed no significant changes between the treatment 
groups and control groups in both sexes. The rising serum level of 
alkaline phosphate reflects changes in the biliary flow [40]. Alkaline 
phosphate is also associated with the bone disorder such as bone 
mineralization [41]. Therefore, serum alkaline phosphate is one of 
the indicators of liver damage [42]. Based on the findings thus far, 
this current study concluded that the treatments in this study did 
not contribute to liver damage. 
Serum protein could be used as an indicator to assess the synthetic 
and regenerative capacity of the liver because most of it is 
synthesized in hepatocytes. A decrease in serum proteins is thus 
likely to suggest chronic damage, whereas a rise in the level of serum 
proteins is likely to indicate tissue injury [43]. An increase in the 
serum concentration of total protein and cholesterol caused by the 
treatment with the extract may stimulate synthesis. These increases 
cannot be attributed to liver damage as no histological lesions were 
observed in the hepatic tissue. The results of the present study did 
not show any significant differences in the serum protein between 
the MECN treated groups and control groups. One can deduce that a 
selected dosage of Clinacanthus nutans does not have any significant 
effects on the changes of serum total protein liver parameters [44]. 
Serum albumin is another parameter related to liver function. 
Albumin, the major serum protein, is responsible for binding a wide 
variety of lipophilic compounds including steroids, lipophilic 
hormones, and phytochemicals that bind to hormone receptors [45]. 
It is an agent that binds asialoglycoprotein, and the density of the 
receptor is highly related to liver function cells [46]. According to 
Tanizawa et al. [47] the acute inflammatory factor is a result of 
reduced serum albumin. Additionally, the albumin levels are usually 
reduced in chronic liver diseases, congestive heart failure and 
nephritis [34]. The present study found no evidence of significant 
differences in serum albumin between the MECN treated and control 
groups for male and female mice. The present study suggests that 
MECN had no adverse effects on the liver.  
Bilirubin is a product of heme moiety of hemoglobin molecules that 
is synthesized in the liver. The high level of bilirubin is usually 
present in abnormal bilirubin metabolism leading to jaundice. 
Heightened levels of serum bilirubin may result from excessive 
hemolysis, cytotoxicity to the liver, or from an obstruction of bile 
ducts that causes cholestasis [34]. The reports of the present study 
found no significant increases in the levels of alkaline phosphate, 
bilirubin and total protein between the treated and control mice in 
both sexes. This suggests that the MECN does not cause damage to 
the liver. In a study by Okokon et al. [34] the administration of crude 
root extract of Croton zambesicus in rats (27-81 mg/kg) for 21 d 
increased the level of serum total protein, alkaline phosphate, total 
bilirubin, and total cholesterol. However, the histological study did 
not notice any lesion in the liver tissue after being treated with the 
extract. This could be due to the fact that the liver repair mechanism 
must have repaired the injury along with the liver cells, and thus no 
injury was spotted. Increases in transaminases and alkaline 
phosphate without substantial necrosis of the liver have been 
reported previously. So, since the alkaline phosphate level was 
unaffected, the injury in the liver may have been at the cellular level 
and was compensated through the repair mechanism of the liver 
[34]. However, the decreases in those serum biochemistry values 
might be due to certain body compensatory mechanisms, body 
utilization, alterations or maintenance of the body in normal 
condition [19]. They could also be due to half-life enzymes in the 
blood. The level of enzymes that increased after an acute injury may 
be reduced to their one’s half over a period of time. The normality of 
serum biochemical parameters in MECN treated group could be due 
to the cytoprotective effect of extracts towards the muscle or liver 
[19]. This result supports similar findings [19,35,48], and thus MECN 
treatment can be considered to be safe for use in the subsequent 
animal model studies. The histopathological examination of liver 
tissue is required to support the cytoprotective effect of the herbs. 
The electrolytes potassium and chloride are markers of kidney 
function. The serum levels of potassium, chloride, urea, and 
creatinine were not affected by the treatment of mice with MECN all 
throughout the study. However, the sodium level has significantly 
decreased in the male group treated with 2000 mg/kg MECN 
compared to the control groups. This indicates that the extract is not 
nephrotoxic and the histological studies of kidney revealed no 
pathological lesions [34]. Therefore, the MECN is not nephrotoxic.  
The histological examination is the basis for establishing treatments 
related to pathological changes in the cell structure of organs [30]. 
Since the liver and kidney in this study were the two most important 
organs in the detoxification process, their histological examination 
has revealed normal hepatocytes and insignificant changes in the 
structure of the hepatocytes, hepatic artery, bile duct, portal vein 
and sinusoid in liver tissue. The liver is a strong organ with superior 
regeneration capability. As such, its function does not keep the same 
upon the exposure to toxicity. The results of this study have 
reported no signs of an inflammatory reaction. Additionally, there 
were no signs of necrosis, local fatty degeneration, hemorrhage, and 
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inflammation infiltration. The kidney micrograph revealed 
noticeable glomeruli, capsules and Bowman’s space in both dose of 
treated and control groups in both sexes. This result is in line with 
previous findings reported by Zakaria et al. [25]. They used MECN 
with doses of 50, 500 and 2500 mg/kg given over a period of 28 d 
and found no toxicity signs in the liver and kidney tissues in both 
sexes of mice. However, this result does not support the findings 
reported by Asyura et al. [19]. They reported that administering 
ethanol extract of Clinacanthus nutans to male Sprague-Dawley rats 
with doses of 125 and 250 mg/kg that were daily given over a 
period of 90 d caused hepatotoxicity and renal toxicity. This 
discrepancy between results could be due to differences in the 
species, where mice may be more resistant to the induction of 
vascular damage than rats [49]. Nevertheless, strain differences in 
response to xenobiotics are almost universal. They include 
differences in acute toxicity, neurotoxicity, carcinogenesis, 
teratogenesis and immunotoxicological reactions[50]. Research has 
also found that a high dose of streptozotocin (STZ) 100 to 200 
mg/kg can cause diabetes in mice, whereas a dose of 35-65 mg/kg 
can cause the same effect in rats [51]. In other words, the mice are 
more resistant to the compound than the rats [52]. These findings 
show that MECN is safe. The toxic phytochemicals are known to alter 
the normal range of their parameters. However, this was not 
observed in the study. The results suggest that MECN does not 
change the structure of the liver or kidney cells and thus they further 
confirm the non-toxic nature of MECN. The 28 d oral toxicity 
research has indeed been advocated as a fundamental test to assess 
the safety of an extract and thus it has been used in many safety 
assessment studies [36]. According to previous investigations, no 
observed adverse effect level of MECN for mice can be considered 
2000 mg/kg under the condition of this investigation. Farsi et al. 
[53] investigated the correlation between dose and period of 
exposure using male and female rats. They found that when the 
treatments had longer durations, the level of alkaline phosphate 
decreased when the rats were orally treated with 2000 mg/kg of 
aqueous Clinacanthus nutans, irrespective of the fact that this 
decrease was within the physiological range and was clinically 
insignificant. Nonetheless, there was an increase in the body weight 
on day 42 and a decrease on day 77, particularly those rats treated 
with 500 mg/kg. There were no significant changes observed in the 
group administered with 2000 mg/kg. Mutagenicity, the tendency of 
a test compound to induce DNA changes.  
CONCLUSION 
This study showed that MECN at dosages up to 2000 mg/kg is safe to 
be used in mice regardless of their sex. There were no significant 
changes in the body weight, hematological, biochemical and 
histology signs of toxicity. However, the level of sodium significantly 
decreased in the mice treated with 2000 mg/kg of MECN compared 
to those of the control group of male mice. It is crucial for one to 
understand the toxicity of this plant before developing it to a new 
herbal medication 
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